Emergence of resistance in Pseudomonas aeruginosa and Acinetobacter species after the use of antimicrobials for burned patients

被引:25
作者
Ferreira, ACB [1 ]
Gobara, S [1 ]
Costa, SF [1 ]
Sauaia, N [1 ]
Mamizuka, EM [1 ]
Van der Heijden, IM [1 ]
Soares, RE [1 ]
Almeida, GD [1 ]
Fontana, C [1 ]
Levin, AS [1 ]
机构
[1] Univ Sao Paulo, Fac Med, Hosp Clin, Sao Paulo, SP, Brazil
关键词
D O I
10.1086/502311
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVES: To evaluate the emergence of resistance of Pseudomonas aeruginosa and Acinetobacter species to imipenem, ciprofloxacin, or both after the use of these drugs and to compare resistant with susceptible isolates by molecular typing. DESIGN: Cohort study. SETTING: Burn intensive care unit (ICU) with 4 beds in a tertiary-care university hospital. METHODS: During 16 months, surveillance cultures were performed for all patients admitted to the ICU. Demographic information was obtained for each patient. Molecular typing was done by pulsed-field gel electrophoresis using restriction enzymes for 71 isolates of P aeruginosa and Acinetobacter species. RESULTS: Thirty-four patients were admitted and 22 were colonized by susceptible P aeruginosa or Acinetobacter species before they used the antimicrobials. Nine (41%) of these patients had a resistant isolate after antimicrobial use: 5 had used imipenem alone, I had used ciprofloxacin, and 3 had used both drugs. The interval between isolation of the susceptible and resistant isolates ranged from 4 to 25 days, but was 10 or more days for 6 patients. Molecular typing revealed that susceptible and resistant isolates from each patient were different and that although there were no predominant clones among susceptible isolates, there was a predominant clone among resistant isolates of P aeruginosa and of Acinetobacter. CONCLUSIONS: Resistance was not due to the acquisition of resistance mechanisms by a previously susceptible strain, but rather to cross-transmission. Although various measures involving antimicrobial use have received great attention, it would seem that practices to prevent cross-transmission are more important in controlling resistance.
引用
收藏
页码:868 / 872
页数:5
相关论文
共 25 条
  • [1] Nosocomial infections caused by multiresistant Pseudomonas aeruginosa
    Arruda, EAG
    Marinho, IS
    Boulos, M
    Sinto, SI
    Caiaffa, HH
    Mendes, CM
    Oplustil, CP
    Sader, H
    Levy, CE
    Levin, AS
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1999, 20 (09) : 620 - 623
  • [2] Emergence of antibiotic-resistant Pseudomonas aeruginosa:: Comparison of risks associated with different antipseudomonal agents
    Carmeli, Y
    Troillet, N
    Eliopoulos, GM
    Samore, MH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) : 1379 - 1382
  • [3] Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic
    Cheng, K
    Smyth, RL
    Govan, JRW
    Doherty, C
    Winstanley, C
    Denning, N
    Heaf, DP
    vanSaene, H
    Hart, CA
    [J]. LANCET, 1996, 348 (9028) : 639 - 642
  • [4] ENTEROBACTER BACTEREMIA - CLINICAL-FEATURES AND EMERGENCE OF ANTIBIOTIC-RESISTANCE DURING THERAPY
    CHOW, JW
    FINE, MJ
    SHLAES, DM
    QUINN, JP
    HOOPER, DC
    JOHNSON, MP
    RAMPHAL, R
    WAGENER, MM
    MIYASHIRO, DK
    YU, VL
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) : 585 - 590
  • [5] Fridkin SK, 2003, CLIN INFECT DIS, V36, P1438, DOI 10.1086/375082
  • [6] Hodges BM, 2001, ANN PHARMACOTHER, V35, P1224
  • [7] Hsueh PR, 2002, EMERG INFECT DIS, V8, P827
  • [8] THE RELATIONSHIP BETWEEN ANTECEDENT ANTIBIOTIC USE AND RESISTANCE TO EXTENDED-SPECTRUM CEPHALOSPORINS IN GROUP-I BETA-LACTAMASE-PRODUCING ORGANISMS
    JACOBSON, KL
    COHEN, SH
    INCIARDI, JF
    KING, JH
    LIPPERT, WE
    IGLESIAS, T
    VANCOUWENBERGHE, CJ
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 21 (05) : 1107 - 1113
  • [9] APACHE-II - A SEVERITY OF DISEASE CLASSIFICATION-SYSTEM
    KNAUS, WA
    DRAPER, EA
    WAGNER, DP
    ZIMMERMAN, JE
    [J]. CRITICAL CARE MEDICINE, 1985, 13 (10) : 818 - 829
  • [10] A SIMPLE GUIDE TO BURN-TREATMENT
    LATARJET, J
    [J]. BURNS, 1995, 21 (03) : 221 - 225